Clinical Trial Update: Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing besifloxacin ophthalmic suspension with gatifloxacin ophthalmic solution in neonates with bacterial conjunctivitis was terminated; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• BESIVANCE (besifloxacin)
• Gatifloxacin ophthalmic solution (gatifloxacin)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Bacterial Conjunctivitis | Phase 3 | Status: TERMINATED | Results posted: 2014-09-03